Edward M. Kaye
2017 - Sarepta Therapeutics
In 2017, Edward M. Kaye earned a total compensation of $4.8M as Former President and Chief Executive Officer at Sarepta Therapeutics, a 39% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,603,820 |
|---|---|
| Salary | $346,923 |
| Stock Awards | $2,314,185 |
| Other | $513,708 |
| Total | $4,778,636 |
Kaye received $2.3M in stock awards, accounting for 48% of the total pay in 2017.
Kaye also received $1.6M in option awards, $346.9K in salary and $513.7K in other compensation.
Rankings
In 2017, Edward M. Kaye's compensation ranked 2,018th out of 14,666 executives tracked by ExecPay. In other words, Kaye earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,018 out of 14,666 | 86th |
Division Manufacturing | 687 out of 5,770 | 88th |
Major group Chemicals And Allied Products | 184 out of 2,074 | 91st |
Industry group Drugs | 137 out of 1,730 | 92nd |
Industry Pharmaceutical Preparations | 104 out of 1,329 | 92nd |
Source: SEC filing on April 26, 2018.
Kaye's colleagues
We found six more compensation records of executives who worked with Edward M. Kaye at Sarepta Therapeutics in 2017.
2017
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2017
Guriqbal Basi
Sarepta Therapeutics
Chief Scientific Officer
2017
Alexander Cumbo
Sarepta Therapeutics
Senior Vice President, Chief Commercial Officer
2017
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2017
David Howton
Sarepta Therapeutics
General Counsel
2017
Catherine Stehman-Breen
Sarepta Therapeutics